Clinical Trial Update: Efficacy and Safety of Camrelizumab Plus Rivoceranib and Local Therapy for Hepatocellular Carcinoma With Lung Metastases (CAPLocal) : A Multicentre, Single-Arm,Prospective Cohort Study

View source ↗

Summary

This document outlines the CAPLocal study, a multicentre, single-arm prospective cohort evaluating camrelizumab plus rivoceranib with local therapy for hepatoce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Camrelizumab (camrelizumab)
• Rivoceranib (rivoceranib)

Snippet

Sponsor: Xiangya Hospital of Central South University | Conditions: Hepatecellular Carcinoma | Status: NOT_YET_RECRUITING